These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

239 related articles for article (PubMed ID: 16834933)

  • 1. Midterm outcomes of percutaneous transluminal septal myocardial ablation in patients with hypertrophic obstructive cardiomyopathy refractory to medication.
    Chen SL; Ye F; Xu ZL; Lin S; Duan BX; Dai ZL; Shan SJ; Zhang JJ
    Chin Med J (Engl); 2006 Jul; 119(13):1121-4. PubMed ID: 16834933
    [No Abstract]   [Full Text] [Related]  

  • 2. Complications of percutaneous transluminal septal myocardial ablation in hypertrophic obstructive cardiomyopathy.
    Zhang W; Li Z; Zhang M; Yuan L; Guan R; Hou A; Jin Y; Deng Z
    Chin Med J (Engl); 2002 Sep; 115(9):1283-6. PubMed ID: 12411095
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Role of percutaneous septal ablation in hypertrophic obstructive cardiomyopathy.
    Kimmelstiel CD; Maron BJ
    Circulation; 2004 Feb; 109(4):452-6. PubMed ID: 14757682
    [No Abstract]   [Full Text] [Related]  

  • 4. Comparison of surgical septal myectomy and alcohol septal ablation with cardiac magnetic resonance imaging in patients with hypertrophic obstructive cardiomyopathy.
    Valeti US; Nishimura RA; Holmes DR; Araoz PA; Glockner JF; Breen JF; Ommen SR; Gersh BJ; Tajik AJ; Rihal CS; Schaff HV; Maron BJ
    J Am Coll Cardiol; 2007 Jan; 49(3):350-7. PubMed ID: 17239717
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Balloon rupture and alcohol leakage into the left anterior descending coronary artery during percutaneous septal ablation for hypertrophic obstructive cardiomyopathy].
    Antolinos Pérez MJ; de la Morena Valenzuela G; Gimeno Blanes JR; Cerdán Sánchez Mdel C; Hurtado Martínez JA; Valdés Chavarri M
    Rev Esp Cardiol; 2005 Jul; 58(7):872-4. PubMed ID: 16022820
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Delayed electrocardiographic changes after percutaneous transluminal septal myocardial ablation in hypertrophic obstructive cardiomyopathy.
    Guo H; Wang P; Xing Y; Peng F; Jiang J; Yang B; You B; Qiu Y; Lee JD
    J Electrocardiol; 2007 Oct; 40(4):356.e1-6. PubMed ID: 17316677
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Survival and sudden cardiac death after septal ablation for hypertrophic obstructive cardiomyopathy.
    Jensen MK; Havndrup O; Hassager C; Helqvist S; Kelbæk H; Jørgensen E; Køber L; Bundgaard H
    Scand Cardiovasc J; 2011 Jun; 45(3):153-60. PubMed ID: 21604920
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Percutaneous septal ablation for hypertrophic cardiomyopathy and mid-ventricular obstruction.
    Seggewiss H; Faber L
    Eur J Echocardiogr; 2000 Dec; 1(4):277-80. PubMed ID: 11916606
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Percutaneous versus surgical treatment for patients with hypertrophic obstructive cardiomyopathy and enlarged anterior mitral valve leaflets.
    van der Lee C; ten Cate FJ; Geleijnse ML; Kofflard MJ; Pedone C; van Herwerden LA; Biagini E; Vletter WB; Serruys PW
    Circulation; 2005 Jul; 112(4):482-8. PubMed ID: 16027255
    [TBL] [Abstract][Full Text] [Related]  

  • 10. In percutaneous transluminal septal myocardial ablation for hypertrophic obstructive cardiomyopathy, it is not the speed of intracoronary alcohol injection but the amount of alcohol injected that determines the resultant infarct size.
    Cheng TO
    Circulation; 2004 Jul; 110(3):e23; author reply e23. PubMed ID: 15262858
    [No Abstract]   [Full Text] [Related]  

  • 11. Percutaneous transluminal septal myocardial ablation in a child with hypertrophic obstructive cardiomyopathy and Noonan syndrome.
    Singh H; Kalra R; Keshavamurthy GB; Singh M; Singh C
    Congenit Heart Dis; 2008; 3(5):347-51. PubMed ID: 18837814
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Management of complete heart block following percutaneous transluminal septal myocardial ablation for patients with hypertrophic cardiomyopathy.
    Cheng TO
    Int J Cardiol; 2009 Jan; 131(3):420. PubMed ID: 18023896
    [No Abstract]   [Full Text] [Related]  

  • 13. Transcoronary ablation of septal hypertrophy compared with surgery in the treatment of hypertrophic obstructive cardiomyopathy.
    Jiang TY; Wu XS; Lu Q; Meng X; Jia CQ; Zhang Y
    Chin Med J (Engl); 2004 Feb; 117(2):296-8. PubMed ID: 14975219
    [No Abstract]   [Full Text] [Related]  

  • 14. Hypertrophic obstructive cardiomyopathy and septal ablation.
    Steinbis S
    Crit Care Nurse; 2003 Jun; 23(3):47-50. PubMed ID: 12830780
    [No Abstract]   [Full Text] [Related]  

  • 15. Quantitative and qualitative changes in the resting electrocardiograph after percutaneous transluminal septal myocardial ablation for the treatment of symptomatic obstructive hypertrophic cardiomyopathy.
    Thai WE; Antonis PR; Hope SA; Meredith IT
    Heart Lung Circ; 2008 Oct; 17(5):364-9. PubMed ID: 18657474
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Long-term electrocardiographic findings in patients with hypertrophic obstructive cardiomyopathy after percutaneous transluminal septal myocardial ablation.
    Haghjoo M
    J Electrocardiol; 2007 Oct; 40(4):357.e1-2. PubMed ID: 17599476
    [No Abstract]   [Full Text] [Related]  

  • 17. Percutaneous septal ablation in hypertrophic obstructive cardiomyopathy.
    Faber L
    Eur J Med Res; 2006 Oct; 11(10):423-31. PubMed ID: 17107876
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Aspects of treatment of hypertrophic obstructive cardiomyopathy with emphasis on the role of percutaneous transluminal ablation of the myocardial septum].
    Veselka J
    Vnitr Lek; 2001 Dec; 47(12):887-91. PubMed ID: 11826555
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The relation between His bundle and the first septal perforating artery: implications for percutaneous transluminal septal myocardial ablation.
    Cui W; Liu F; Zu X; Du J; Hao Y; Li Y; Li B; Wu J
    Int J Cardiol; 2004 Dec; 97(3):579-80. PubMed ID: 15561357
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Alcohol septal ablation versus surgical septal myectomy: comparison of effects on atrioventricular conduction tissue.
    Talreja DR; Nishimura RA; Edwards WD; Valeti US; Ommen SR; Tajik AJ; Dearani JA; Schaff HV; Holmes DR
    J Am Coll Cardiol; 2004 Dec; 44(12):2329-32. PubMed ID: 15607394
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.